Frequently mutated genes in breast cancer CTCs include TP53 (mostly in TNBC), PIK3CA, ERBB2, KRAS and ESR1. Moreover, mutations in these genes display high degree of intra-patient heterogeneity [23,24]. Here, ERBB2 is linked to breast carcinoma.